NCT00484575View on ClinicalTrials.gov

Inhaled Sevoflurane Compared to Intravenous Sedation Post Coronary Artery Bypass Grafting

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

December 31, 2008

Conditions
Myocardial Reperfusion InjuryAtrial Fibrillation
Interventions
DRUG

Sevoflurane

given by infusion via AnaConDa for sedation with target MAAS 2-3

DRUG

propofol

propofol given intravenously for sedation in control group

Trial Locations (1)

171 76

Karolinska University Hospital Solna, Cardiothoracic Intensive Care Unit, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT00484575 - Inhaled Sevoflurane Compared to Intravenous Sedation Post Coronary Artery Bypass Grafting | Biotech Hunter | Biotech Hunter